Status:
COMPLETED
Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects
Lead Sponsor:
AstraZeneca
Conditions:
Carotid Artery Stenosis
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to examine the changes in the carotid artery when subjects receive high or low doses of rosuvastatin.
Eligibility Criteria
Inclusion
- Fasting blood low density lipoprotein cholesterol level as defined by the protocol
- Diagnosed carotid arterial stenosis
Exclusion
- The use of lipid lowering drugs or dietary supplements after Visit 1.
- Heavy or total occlusion of the carotid artery or recent stroke
- Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2004
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00654394
Start Date
January 1 2000
End Date
August 1 2004
Last Update
March 16 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.